Amgen suffers setback as patent office refuses to review competitor’s drug
East Ventura County, Health Care & Life Science, Latest newsThe U.S. Patent and Trademark Office handed Amgen a potential setback Jan. 14 when it declined to review two patent expiration dates on a competitor’s drug. In June, Thousand Oaks-based biotech giant Amgen asked the agency to review two formulation patents for Humira, made by Chicago-based competitor AbbVie, arguing that the patents should not have Read More →
Limoneira misses Wall Street expectations for fourth quarter
Agribusiness, Earnings, Latest news, Tri-County Public CompaniesSanta Paula-based Limoneira Co. reported fiscal fourth-quarter net income of $654,000 on Jan. 11 after reporting a loss in the same period a year earlier. The company said it had profit of 4 cents per share. Losses, adjusted for non-recurring gains, came to 23 cents per share. The results did not meet Wall Street expectations. Read More →
Shire acquiring Baxalta for $32 billion
Health Care & Life Science, Latest news, TechnologyShire PLC sweetened the pot and Baxalta Inc. investors took the bait in a deal announced early Jan. 11. Dublin-based Shire announced a $30 billion bid for Deefield, Ill.-based Baxalta on Aug. 4. On Jan. 11, the companies announced Shire will acquire Baxalta for $32 billion. Baxalta employs about 2,000 people in Thousand Oaks and Read More →
Settlement ends Amgen drug kickback saga
East Ventura County, Health Care & Life Science, Latest news, Tri-County Public CompaniesA drug kickback program is finally behind Amgen, the Thousand Oaks-based pharmaceutical giant. Louisville, K.Y.-based PharMerica was the last of three companies to settle lawsuits relating to Amgen allegedly paying kickbacks to PharMerica and another company to prescribe patients the anemia drug Aranesp. PharMerica settled the suit for $2.5 million in December, Louisville Business First Read More →